Sotio AS, a Czech biotechnology company owned by the country’s billionaire Petr Kellner, will present the American Society of Clinical Oncology with its treatment for prostate cancer, a step towards getting the therapy ready for a commercial registration.
![](https://praguemonitor.com/wp-content/uploads/2023/11/f-meyqwiaai6ru-3-300x300.jpg)